TY - JOUR AU - Brown, S. PY - 2012 DA - 2012// TI - Shock, terror and controversy: how the media reacted to the Women’s Health Initiative JO - Climacteric VL - 15 UR - https://doi.org/10.3109/13697137.2012.660048 DO - 10.3109/13697137.2012.660048 ID - Brown2012 ER - TY - JOUR AU - McIntyre, R. S. AU - Konarski, J. Z. AU - Grigoriadis, S. AU - Fan, N. C. AU - Mancini, D. A. AU - Fulton, K. A. PY - 2005 DA - 2005// TI - Hormone replacement therapy and antidepressant prescription patterns: a reciprocal relationship JO - CMAJ VL - 172 UR - https://doi.org/10.1503/cmaj.1040517 DO - 10.1503/cmaj.1040517 ID - McIntyre2005 ER - TY - JOUR AU - Utian, W. H. PY - 2007 DA - 2007// TI - Feminine Forever, Round 2: The Bioidentical Cult JO - Menopause Management VL - 16 ID - Utian2007 ER - TY - JOUR PY - 2012 DA - 2012// TI - Drugs for menopausal symptoms JO - Med Lett Drugs Ther VL - 54 ID - ref4 ER - TY - JOUR AU - Pinkerton, J. V. PY - 2014 DA - 2014// TI - Think Twice Before Prescribing Custom-Compounded Bioidentical Hormone Therapy JO - J Women’s Health VL - 23 UR - https://doi.org/10.1089/jwh.2014.1505 DO - 10.1089/jwh.2014.1505 ID - Pinkerton2014 ER - TY - JOUR AU - Reid, R. L. PY - 2002 DA - 2002// TI - Translating the latest scientific advances into clinical practice JO - JOGC VL - 24 ID - Reid2002 ER - TY - JOUR AU - Langer, R. D. AU - Manson, J. A. AU - Allison, M. A. PY - 2012 DA - 2012// TI - Have we come full circle or moved on? The Women’s Health Initiative 10 yrs on JO - Climacteric VL - 15 UR - https://doi.org/10.3109/13697137.2012.666916 DO - 10.3109/13697137.2012.666916 ID - Langer2012 ER - TY - JOUR AU - Stuenkel, C. A. AU - Gass, M. L. S. AU - Manson, J. E. AU - Lobo, R. A. AU - Pal, L. AU - Rebar, R. W. PY - 2012 DA - 2012// TI - A decade after the Women’s Health Initiative- the experts do agree JO - Fertil Steril VL - 98 UR - https://doi.org/10.1016/j.fertnstert.2012.05.051 DO - 10.1016/j.fertnstert.2012.05.051 ID - Stuenkel2012 ER - TY - JOUR AU - Hale, G. E. AU - Hughes, C. L. AU - Burger, H. G. AU - Robertson, D. M. AU - Fraser, I. S. PY - 2009 DA - 2009// TI - Atypical estradiol secretion and ovulation patterns caused by luteal out-of-phase (LOOP) events underlying irregular ovulatory menstrual cycles in the menopausal transition JO - Menopause VL - 16 UR - https://doi.org/10.1097/gme.0b013e31817ee0c2 DO - 10.1097/gme.0b013e31817ee0c2 ID - Hale2009 ER - TY - JOUR PY - 1996 DA - 1996// TI - Research on Menopause in the 1990s. Report of a WHO Scientific Group JO - WHO Technical Report Series VL - 866 ID - ref10 ER - TY - STD TI - Harlow SD, Gass M, Hall JE, Lobo R, Maki P, Rebar RW et al. Executive summary of the Stages of Reproductive Aging +10: Adressing the unfinished agenda of staging reproductive aging. Menopause. 2012;19(4):387–95. ID - ref11 ER - TY - JOUR AU - Gold, E. B. AU - Block, G. AU - Crawford, S. AU - Lachance, L. AU - FitzGerald, G. AU - Miracle, H. PY - 2004 DA - 2004// TI - Lifestyle and demographic factors in relation to vasomotor symptoms: baseline results from the Study of Women’s Health Across the Nation. SWAN study JO - Am J Epidemiol VL - 159 UR - https://doi.org/10.1093/aje/kwh168 DO - 10.1093/aje/kwh168 ID - Gold2004 ER - TY - JOUR AU - Guthrie, J. R. AU - Dennerstein, L. AU - Taffe, J. R. AU - Lehert, P. AU - Burger, H. G. PY - 2004 DA - 2004// TI - The menopausal transition: a 9-year prospective population-based study. The Melbourne Women’s Midlife Health Project JO - Climacteric VL - 7 UR - https://doi.org/10.1080/13697130400012163 DO - 10.1080/13697130400012163 ID - Guthrie2004 ER - TY - JOUR AU - Szoeke, C. E. AU - Cicuttini, F. AU - Guthrie, J. AU - Dennerstein, L. PY - 2005 DA - 2005// TI - Self-reported arthritis and the menopause JO - Climacteric VL - 8 UR - https://doi.org/10.1080/13697130400012296 DO - 10.1080/13697130400012296 ID - Szoeke2005 ER - TY - JOUR AU - Toffol, E. AU - Heikinheimo, O. AU - Partonen, T. PY - 2015 DA - 2015// TI - Hormone therapy and mood in perimenopausal and postmenopausal women: a narrative review JO - Menopause VL - 22 UR - https://doi.org/10.1097/GME.0000000000000323 DO - 10.1097/GME.0000000000000323 ID - Toffol2015 ER - TY - JOUR AU - Levine, K. B. AU - Williams, R. E. AU - Hartmann, K. E. PY - 2008 DA - 2008// TI - Vulvovaginal atrophy is strongly associated with female sexual dysfunction among sexually active postmenopausal women JO - Menopause VL - 15 UR - https://doi.org/10.1097/gme.0b013e31815a5168 DO - 10.1097/gme.0b013e31815a5168 ID - Levine2008 ER - TY - JOUR AU - Raz, R. AU - Stamm, W. PY - 1993 DA - 1993// TI - A controlled trial of intravaginal estriol in postmenopausal women with recurrent urinary tract infections JO - N Engl J Med VL - 329 UR - https://doi.org/10.1056/NEJM199309093291102 DO - 10.1056/NEJM199309093291102 ID - Raz1993 ER - TY - JOUR AU - Khoudray, S. R. AU - Wildman, R. P. AU - Matthews, K. AU - Thurston, R. C. AU - Bromberg, J. T. AU - Sutton-Tyrrell, K. PY - 2012 DA - 2012// TI - Endogenous sex hormones impact the progression of subclinical atherosclerosis in women during the menopausal transition JO - Atherosclerosis VL - 225 UR - https://doi.org/10.1016/j.atherosclerosis.2012.07.025 DO - 10.1016/j.atherosclerosis.2012.07.025 ID - Khoudray2012 ER - TY - STD TI - Khan A, Fortier M. SOGC Menopause and Osteoporosis Working Group. Osteoporosis in Menopause. SOGC Clinical Practice Guideline 312. JOGC. 2014;36(9):S1–S15. ID - ref19 ER - TY - JOUR AU - Wellons, M. AU - Ouyang, P. AU - Schreiner, P. AU - Herrington, D. M. AU - Vaidya, D. PY - 2012 DA - 2012// TI - Early menopause predicts future coronary heart disease and stroke: the Multi-Ethnic Study of Atherosclerosis JO - Menopause VL - 19 UR - https://doi.org/10.1097/gme.0b013e3182517bd0 DO - 10.1097/gme.0b013e3182517bd0 ID - Wellons2012 ER - TY - JOUR AU - Magliano, M. PY - 2010 DA - 2010// TI - Menopausal arthralgia: Fact or fiction JO - Maturitas VL - 76 UR - https://doi.org/10.1016/j.maturitas.2010.04.009 DO - 10.1016/j.maturitas.2010.04.009 ID - Magliano2010 ER - TY - JOUR AU - Chlebowski, R. T. AU - Cirillo, D. J. AU - Eaton, C. B. AU - Stefanick, M. L. AU - Pettinger, M. AU - Carbone, L. D. PY - 2013 DA - 2013// TI - Estrogen alone and joint symptoms in the Women’s Health Initiative randomized trial JO - Menopause VL - 20 ID - Chlebowski2013 ER - TY - STD TI - Maclennan A, Broadbent JL, Lester S, Moore V. Oral oestrogen and combined oestrogen/progestogen therapy versus placebo for hot flushes. Cochrane Database Syst Rev. 2004;4:CD002978. ID - ref23 ER - TY - JOUR PY - 2004 DA - 2004// TI - Vasomotor Symptoms JO - Obstet Gynecol VL - 4 ID - ref24 ER - TY - JOUR AU - Rigg, L. A. AU - Hermann, H. AU - Yen, S. S. PY - 1978 DA - 1978// TI - Absorption of estrogen from vaginal creams JO - N Engl J Med VL - 298 UR - https://doi.org/10.1056/NEJM197801262980406 DO - 10.1056/NEJM197801262980406 ID - Rigg1978 ER - TY - JOUR AU - Gallagher, J. C. AU - Levine, J. P. PY - 2011 DA - 2011// TI - Preventing osteoporosis in symptomatic postmenopausal women JO - Menopause VL - 18 UR - https://doi.org/10.1097/gme.0b013e3181e324a6 DO - 10.1097/gme.0b013e3181e324a6 ID - Gallagher2011 ER - TY - JOUR AU - Lindsay, R. AU - Hart, D. M. AU - Aitken, J. M. AU - MacDonald, E. B. AU - Anderson, J. B. AU - Clarke, A. C. PY - 1976 DA - 1976// TI - Long-term prevention of postmenopausal osteoporosis by oestrogen. Evidence for an increased bone mass after delayed onset of oestrogen treatment JO - Lancet VL - 1 UR - https://doi.org/10.1016/S0140-6736(76)92217-0 DO - 10.1016/S0140-6736(76)92217-0 ID - Lindsay1976 ER - TY - JOUR AU - Gallagher, J. C. AU - Rapuri, P. B. AU - Haynatzki, G. AU - Detter, J. R. PY - 2002 DA - 2002// TI - Effect of discontinuation of estrogen, calcitriol, and the combination of both on bone density and bone markers JO - JCEM VL - 87 ID - Gallagher2002 ER - TY - STD TI - Reid RL, Abramson BL, Blake J, Desindes S, Dobin S, Johnston S, et al; SOGC Menopause and Osteoporosis Working Group. Managing menopause: SOGC Clinical Practice Guideline 312. JOGC. 2014;36(9):S1–S80. ID - ref29 ER - TY - JOUR AU - Allison, M. A. AU - Manson, J. E. PY - 2006 DA - 2006// TI - Observational studies and clinical trials of menopausal hormone therapy: can they both be right? JO - Menopause VL - 13 UR - https://doi.org/10.1097/01.gme.0000194571.05427.87 DO - 10.1097/01.gme.0000194571.05427.87 ID - Allison2006 ER - TY - JOUR AU - Hodis, H. N. AU - Mack, W. J. PY - 2007 DA - 2007// TI - Hormone therapy and coronary artery calcification JO - N Engl J Med VL - 357 UR - https://doi.org/10.1056/NEJMc072043 DO - 10.1056/NEJMc072043 ID - Hodis2007 ER - TY - JOUR AU - Grodstein, F. AU - Manson, J. E. AU - Colditz, G. A. AU - Willett, W. C. AU - Speizer, F. E. AU - Stampfer, M. J. PY - 2000 DA - 2000// TI - A prospective, observational study of postmenopausal hormone therapy and primary prevention of cardiovascular disease JO - Ann Intern Med VL - 133 UR - https://doi.org/10.7326/0003-4819-133-12-200012190-00008 DO - 10.7326/0003-4819-133-12-200012190-00008 ID - Grodstein2000 ER - TY - STD TI - Allison MA, Manson JE, Langer RD, Carr JJ, Rossouw JE, Pettinger MB, et al. Oophorectomy, hormone therapy, and subclinical coronary artery disease in women with hysterectomy: the Women’s Health Initiative coronary artery calcium study. Menopause. 2008;15(4):639–47. ID - ref33 ER - TY - STD TI - Manson JE, Allison MA, Rossouw JE, Carr JJ, Langer RD, Hsia J, et al. Estrogen Therapy and Coronary-Artery Calcification. N Engl J Med. 2007;356:2591–602. ID - ref34 ER - TY - STD TI - Allison MA, Manson JE, Aragaki A, Langer RD, Rossouw J, Curb D, et al. Vasomotor symptoms and coronary artery calcium in postmenopausal women. Menopause. 2010;17(6):1136–45. ID - ref35 ER - TY - JOUR AU - Hulley, S. AU - Grady, D. AU - Bush, T. AU - Furberg, C. AU - Herrington, D. AU - Riggs, B. PY - 1998 DA - 1998// TI - For the Heart and Estrogen/ progestin replacement study (HERS) Research Group. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women JO - JAMA VL - 280 UR - https://doi.org/10.1001/jama.280.7.605 DO - 10.1001/jama.280.7.605 ID - Hulley1998 ER - TY - JOUR AU - Salpeter, S. R. AU - Walsh, J. M. E. AU - Greyber, E. AU - Salpeter, E. E. PY - 2006 DA - 2006// TI - Coronary heart disease events associated with hormone therapy in younger and older women: a meta-analysis JO - J Gen Intern Med VL - 21 UR - https://doi.org/10.1111/j.1525-1497.2006.00389.x DO - 10.1111/j.1525-1497.2006.00389.x ID - Salpeter2006 ER - TY - STD TI - Rossouw JE, Prentice RL, Manson JE, Wu L, Barad D, Barnabei VM, et al. Postmenopausal hormone therapy and risk of cardiovascular disease by age and years since menopause. JAMA. 2007;297(13):1465–77. ID - ref38 ER - TY - JOUR AU - Holm, P. AU - Andersen, H. L. AU - Andersen, M. R. AU - Erhardtsen, E. AU - Steen, S. PY - 1999 DA - 1999// TI - The direct antiatherogenic effect of estrogen is present, absent or reversed, depending on the state of the arterial endothelium: A time course study in cholesterol-clamped rabbits JO - Circulation VL - 100 UR - https://doi.org/10.1161/01.CIR.100.16.1727 DO - 10.1161/01.CIR.100.16.1727 ID - Holm1999 ER - TY - JOUR AU - Grodstein, F. AU - Manson, J. A. AU - Stampfer, M. J. PY - 2006 DA - 2006// TI - Hormone therapy and coronary heart disease: The role of time since menopause and age at hormone initiation JO - J Women’s Health VL - 15 UR - https://doi.org/10.1089/jwh.2006.15.35 DO - 10.1089/jwh.2006.15.35 ID - Grodstein2006 ER - TY - JOUR AU - Clarkson, T. B. PY - 2007 DA - 2007// TI - Estrogen effects on arteries vary with stage of reproductive life and extent of subclinical atherosclerosis progression JO - Menopause VL - 14 UR - https://doi.org/10.1097/GME.0b013e31803c764d DO - 10.1097/GME.0b013e31803c764d ID - Clarkson2007 ER - TY - STD TI - Depypere HT, Tummers P, De Bacquer D, De Backer G, Do M, Dhont M. Number of women needed in a prospective trial to prove potential cardiovascular benefit of hormone replacement therapy. Climacteric. 2007;10:238–43. ID - ref42 ER - TY - STD TI - Margolis KL, Bonds DE, Rodabough RJ, Tinker L, Phillips LS, Allen C, et al. Effect of oestrogen plus progestin on the incidence of diabetes in postmenopausal women: results from the Women’s Health Initiative Hormone Trial. Diabetologia. 2004;47:1175–87. ID - ref43 ER - TY - STD TI - Manson JE, Chlebowski RT, Stefanick ML, Aragaki Ak, Rossouw JE, Prentice RL, et al. Menopausal hormone therapy and health outcomes during the intervention and extended post stopping phases of the Women’s Health Initiative randomized trials. JAMA. 2013;310(13):1353–68. ID - ref44 ER - TY - JOUR AU - Sites, C. K. AU - L’Hommedieu, G. D. AU - Toth, M. J. AU - Brochu, M. AU - Cooper, B. C. AU - Fairhurst, P. A. PY - 2005 DA - 2005// TI - The effect of hormone replacement therapy on body composition, body fat distribution, and insulin sensitivity in menopausal women: a randomized double blind, placebo controlled trial JO - J Clin Endocrinol Metab VL - 90 UR - https://doi.org/10.1210/jc.2004-1479 DO - 10.1210/jc.2004-1479 ID - Sites2005 ER - TY - JOUR AU - Norman, R. J. AU - Flight, I. H. AU - Rees, M. C. PY - 2000 DA - 2000// TI - Oestrogen and progestogen hormone replacement therapy for peri-menopause and post-menopausal women: Weight and body fat distribution JO - Cochrane Database Syst Rev VL - 2011 ID - Norman2000 ER - TY - JOUR AU - Kim, C. AU - Golden, S. H. AU - Kong, S. AU - Nan, B. AU - Mather, K. J. AU - Barrett-Connor, E. PY - 2014 DA - 2014// TI - Diabetes Prevention Program Research Group. Does hormone therapy affect blood pressure in the Diabetes Prevention Program? JO - Menopause VL - 21 UR - https://doi.org/10.1097/GME.0b013e3182a0e3ea DO - 10.1097/GME.0b013e3182a0e3ea ID - Kim2014 ER - TY - STD TI - Atkin CK, Smith SW, McFeters C, Ferguson V. A comprehensive analysis of breast cancer news coverage in leading media outlets focusing on environmental risks and prevention. J Health Communn. 2008;13(1):3–19. ID - ref48 ER - TY - JOUR AU - Deeks, A. AU - Zoungas, S. AU - Teede, H. PY - 2008 DA - 2008// TI - Risk perception in women: a focus on menopause JO - Menopause VL - 15 UR - https://doi.org/10.1097/gme.0b013e31812f7b65 DO - 10.1097/gme.0b013e31812f7b65 ID - Deeks2008 ER - TY - STD TI - Silverstein MD, Heit JA, Mohr DN, Petterson TM, O'Fallon WM, Melton LJ 3rd. Trends in the incidence of deep vein thrombosis and pulmonary embolism. Arch Intern Med. 1998;158:585–93. ID - ref50 ER - TY - STD TI - Cushman M, Kuller LH, Prentice R, Rodabough RJ, Psaty BM, Stafford RS, et al. Women's Health Initiative Investigators. Estrogen plus progestin and the risk of venous thromboembolism. JAMA. 2004;292:1573–80. ID - ref51 ER - TY - JOUR AU - Blondon, M. AU - Wiggins, K. L. AU - McKnight, B. AU - Psaty, B. M. AU - Rice, K. M. AU - Heckbert, S. R. PY - 2013 DA - 2013// TI - The association of smoking with venous thrombosis in women. A population-based, case–control study JO - Thromb Haemost VL - 109 UR - https://doi.org/10.1160/TH12-10-0732 DO - 10.1160/TH12-10-0732 ID - Blondon2013 ER - TY - JOUR AU - Gavish, I. AU - Brenner, B. PY - 2011 DA - 2011// TI - Air travel and risk of thromboembolism JO - Intern Emerg Med VL - 6 UR - https://doi.org/10.1007/s11739-010-0474-6 DO - 10.1007/s11739-010-0474-6 ID - Gavish2011 ER - TY - JOUR AU - Laliberte, F. AU - Dea, K. AU - Duh, M. S. AU - Kahler, K. H. AU - Rolli, M. AU - Lefebvre, P. PY - 2011 DA - 2011// TI - Does the route of administration for estrogen hormone therapy impact the risk of venous thromboembolism? Estradiol transdermal system versus oral estrogen-only hormone therapy JO - Menopause VL - 18 UR - https://doi.org/10.1097/gme.0b013e3182175e5c DO - 10.1097/gme.0b013e3182175e5c ID - Laliberte2011 ER - TY - JOUR AU - Sweetland, S. AU - Beral, V. AU - Balkwill, A. AU - Liu, B. AU - Benson, V. S. AU - Canonico, M. PY - 2012 DA - 2012// TI - Venous thromboembolism risk in relation to use of different types of postmenopausal hormone therapy in a large prospective study JO - J Thromb Haemost VL - 10 UR - https://doi.org/10.1111/j.1538-7836.2012.04919.x DO - 10.1111/j.1538-7836.2012.04919.x ID - Sweetland2012 ER - TY - STD TI - Wassertheil-Smoller S, Hendrix SL, Limacher M, Heiss G, Kooperberg C, Baird A, et al. The effect of estrogen and progestin on stroke in postmenopausal women. The Women’s Health Initiative: a randomized trial. JAMA. 2003;289:2673–84. ID - ref56 ER - TY - STD TI - Hendrix SL, Wassertheil-Smoller S, Johnson KC, Howard BV, Kooperberg C, Rossouw JE, et al. WHI Investigators. Effects of conjugated equine estrogen on stroke in the Women’s Health Initiative. Circulation. 2006;113:2425–34. ID - ref57 ER - TY - JOUR AU - Birge, S. S. PY - 2006 DA - 2006// TI - Estrogen and stroke: a case for low-dose estrogen JO - Menopause VL - 13 UR - https://doi.org/10.1097/01.gme.0000232280.89842.d0 DO - 10.1097/01.gme.0000232280.89842.d0 ID - Birge2006 ER - TY - STD TI - Renoux C, Dell’Aniello S, Garbe E, Suissa S. Transdermal and oral hormone replacement therapy and the risk of stroke: a nested case–control study. BMJ. 2010;340:c2519. ID - ref59 ER - TY - JOUR AU - Kurman, R. J. AU - Kaminski, P. F. AU - Norris, H. J. PY - 1985 DA - 1985// TI - The behavior of endometrial hyperplasia: a long-term study of “untreated” hyperplasia in 170 patients JO - Cancer VL - 56 UR - https://doi.org/3.0.CO;2-X DO - 3.0.CO;2-X ID - Kurman1985 ER - TY - JOUR AU - Pickar, J. H. AU - Thorneycroft, I. AU - Whitehead, M. PY - 1998 DA - 1998// TI - Effects of hormone replacement therapy on the endometrium and lipid parameters: a review of randomized trials, 1985–1995 JO - Am J Obstet Gynecol VL - 178 UR - https://doi.org/10.1016/S0002-9378(98)70553-8 DO - 10.1016/S0002-9378(98)70553-8 ID - Pickar1998 ER - TY - JOUR AU - Somboonporn, W. AU - Panna, S. AU - Temtanakitpaisan, T. AU - Kaewrudee, S. AU - Soontrapa, S. PY - 2011 DA - 2011// TI - Effects of the levonorgestrel-releasing intrauterine system plus estrogen therapy in perimenopausal and postmenopausal women: systematic review and meta-analysis JO - Menopause VL - 18 UR - https://doi.org/10.1097/gme.0b013e31821606c5 DO - 10.1097/gme.0b013e31821606c5 ID - Somboonporn2011 ER - TY - JOUR AU - Santen, R. J. AU - Kagan, R. AU - Altomare, C. J. AU - Komm, B. AU - Mirkin, S. AU - Taylor, H. S. PY - 2014 DA - 2014// TI - Current and evolving approaches to individualizing estrogen receptor-based therapy for menopausal women JO - J Clin Endocrinol Metab VL - 99 ID - Santen2014 ER - TY - BOOK AU - King, S. PY - 2008 DA - 2008// TI - Breast Cancer and the Politics of Philanthropy PB - University of Minnesota Press CY - Minneapolis, Minn ID - King2008 ER - TY - JOUR AU - Kaunitz, A. M. PY - 2006 DA - 2006// TI - Hormone therapy and breast cancer risk: Trumping fear with facts JO - Menopause VL - 13 UR - https://doi.org/10.1097/01.gme.0000196814.41871.ff DO - 10.1097/01.gme.0000196814.41871.ff ID - Kaunitz2006 ER - TY - JOUR AU - Collins, J. A. PY - 2006 DA - 2006// TI - Hormones and breast cancer. Should practice be changed? JO - Obstet Gynecol VL - 108 UR - https://doi.org/10.1097/01.AOG.0000250085.29809.14 DO - 10.1097/01.AOG.0000250085.29809.14 ID - Collins2006 ER - TY - JOUR AU - Fletcher, S. W. AU - Elmore, J. G. PY - 2003 DA - 2003// TI - Clinical practice: Mammographic screening for breast cancer JO - NEJM VL - 348 UR - https://doi.org/10.1056/NEJMcp021804 DO - 10.1056/NEJMcp021804 ID - Fletcher2003 ER - TY - JOUR PY - 2002 DA - 2002// TI - Risks and benefits of estrogen plus progestin in healthy post-menopausal women: principal results of the Women’s Health Initiative randomized controlled trial JO - JAMA VL - 288 UR - https://doi.org/10.1001/jama.288.3.321 DO - 10.1001/jama.288.3.321 ID - ref68 ER - TY - STD TI - Anderson GL, Chlebowski RT, Aragaki AK,  Kuller LH, Manson JE, Gass M, et al. Conjugated equine oestrogen and breast cancer incidence and mortality in postmenopausal women with hysterectomy: extended follow-up of the Women’s Health Initiative randomized placebo-controlled trial. Lancet Oncol. 2012;13:476–86. ID - ref69 ER - TY - JOUR PY - 2004 DA - 2004// TI - Effects of Conjugated Equine Estrogen in Postmenopausal Women With Hysterectomy The Women’s Health Initiative Randomized Controlled Trial JO - JAMA VL - 291 UR - https://doi.org/10.1001/jama.291.14.1701 DO - 10.1001/jama.291.14.1701 ID - ref70 ER - TY - STD TI - LaCroix AZ, Chlebowski RT, Manson JE, Aragaki AK, Johnson KC, Martin L, et al. WHI Investigators. Health Outcomes After Stopping Conjugated Equine Estrogens Among Postmenopausal Women With Prior Hysterectomy A Randomized Controlled Trial. JAMA. 2011;305(13):1305–14. ID - ref71 ER - TY - JOUR AU - Jick, S. S. AU - Hagberg, K. W. AU - Kaye, J. A. AU - Jick, H. PY - 2009 DA - 2009// TI - Postmenopausal estrogen-containing hormone therapy and risk of breast cancer JO - Obstet Gynecol VL - 113 UR - https://doi.org/10.1097/AOG.0b013e31818fdde4 DO - 10.1097/AOG.0b013e31818fdde4 ID - Jick2009 ER - TY - JOUR PY - 1997 DA - 1997// TI - Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108,411 women without breast cancer JO - Lancet VL - 350 UR - https://doi.org/10.1016/S0140-6736(97)08233-0 DO - 10.1016/S0140-6736(97)08233-0 ID - ref73 ER - TY - STD TI - Colditz GA, Hankinson SE, Hunter DJ, Willett WC, Manson JE, Stampfer MJ, et al. The use of estrogens and progestins and the risk of breast cancer in postmenopausal women. N Engl J Med. 1995;32(24):1589–93. ID - ref74 ER - TY - STD TI - Li CI, Malone KE, Porter PL, Weiss NS, Tang MT, Cushing-Haugen KL, et al. Relationship between long durations and different regimens of hormone therapy and breast cancer risk. JAMA. 2003;289:3254–63. ID - ref75 ER - TY - STD TI - Sprague BL, Trentham-Dietz A, Egan KM, Titus-Ernstoff L, Hamptom JM, Newcomb PA. Proportion of invasive breast cancer attributable to risk factors modifiable after menopause. Am J Epidemiol. 2008;168(4):404–11. ID - ref76 ER - TY - JOUR AU - Singletary, S. E. PY - 2003 DA - 2003// TI - Rating the risk factors for breast cancer JO - Ann Surg VL - 237 ID - Singletary2003 ER - TY - JOUR AU - Reid, R. L. PY - 2013 DA - 2013// TI - STOP enforcing a 5-year rule for menopausal hormone therapy - START individualizing therapy to optimize health and quality of life JO - OBG Management VL - 25 ID - Reid2013 ER - TY - JOUR AU - Grodstein, F. AU - Newcomb, P. A. AU - Stampfer, M. J. PY - 1999 DA - 1999// TI - Postmenopausal hormone therapy and the risk of colorectal cancer: a review and meta-analysis JO - Am J Med VL - 106 UR - https://doi.org/10.1016/S0002-9343(99)00063-7 DO - 10.1016/S0002-9343(99)00063-7 ID - Grodstein1999 ER - TY - JOUR AU - Lin, K. J. AU - Cheung, W. Y. AU - Giovannucci, E. L. PY - 2012 DA - 2012// TI - The effect of estrogen vs combined estrogen-progestogen therapy on the risk of colorectal cancer JO - Intern J Cancer VL - 130 UR - https://doi.org/10.1002/ijc.26026 DO - 10.1002/ijc.26026 ID - Lin2012 ER - TY - JOUR AU - Chan, J. A. AU - Meyerhard, J. A. AU - Chan, A. T. AU - Giovannucci, E. L. AU - Coldit, G. A. AU - Fuchs, C. S. PY - 2006 DA - 2006// TI - Hormone replacement therapy and survival after colorectal cancer diagnosis JO - J Clin Oncol VL - 24 UR - https://doi.org/10.1200/JCO.2006.08.0580 DO - 10.1200/JCO.2006.08.0580 ID - Chan2006 ER - TY - STD TI - Simon MS, Chlebowski RT, Wactawski-Wende J, Johnson KC, Muckovitz A, Kato I, et al. Estrogen plus progestin and colorectal cancer incidence and mortality. J Clin Oncol. 2012;30(32):3983–90. ID - ref82 ER - TY - JOUR AU - Morch, L. S. AU - Lokkegaard, E. AU - Andreasen, A. H. AU - Kjaer, S. K. AU - Lidegaard, O. PY - 2012 DA - 2012// TI - Hormone therapy and different ovarian cancers: a national cohort study JO - Amer J Epidemiol VL - 175 UR - https://doi.org/10.1093/aje/kwr446 DO - 10.1093/aje/kwr446 ID - Morch2012 ER - TY - JOUR AU - Koskela-Niska, V. AU - Lyytinen, H. AU - Riska, A. AU - Pukkala, E. AU - Ylikorkala, O. PY - 2013 DA - 2013// TI - Ovarian cancer risk in Ovarian cancer risk in postmenopausal women using estradiol-progestin therapy - a nationwide study JO - Climacteric VL - 16 UR - https://doi.org/10.3109/13697137.2012.663818 DO - 10.3109/13697137.2012.663818 ID - Koskela-Niska2013 ER - TY - JOUR AU - Taylor, H. S. AU - Manson, J. E. PY - 2011 DA - 2011// TI - Update in hormone therapy use in menopause JO - JCEM VL - 96 ID - Taylor2011 ER - TY - STD TI - Clague J, Reynolds P, Sullivan-Halley J, Ma H, Lacey JV Jr, Henderson KD, et al. Menopausal hormone therapy does not influence lung cancer risk: results from the California Teachers Study. Cancer Epidemiol Biomarkers Prev. 2011;20(3):560–4. ID - ref86 ER - TY - STD TI - Pesatori AC, Carugno M, Consonni D, Hung RJ, Papadoupolos A, Landi MT, et al. Hormone use and risk for lung cancer: a pooled analysis from the International Lung Cancer Consortium. Brit J Cancer. 2013;109(7):1954–64. ID - ref87 ER - TY - JOUR AU - Pines, A. PY - 2011 DA - 2011// TI - Postmenopausal hormone therapy and lung cancer JO - Climacteric VL - 14 UR - https://doi.org/10.3109/13697137.2010.525076 DO - 10.3109/13697137.2010.525076 ID - Pines2011 ER - TY - STD TI - Simonsen MH, Erichsen R, Froslev T, Rungby J, Sorensen HT. Postmenopausal estrogen therapy and risk of gallstone disease: a population-based case–control study. Drug Saf. 2013;36(12):1189–97. ID - ref89 ER - TY - STD TI - Nordenvall C, Oskarsson V, Sadr-Azodi O, Orsini N, Wolk A. Postmenopausal hormone replacement therapy and the risk of cholecystectomy: a prospective cohort study. Scand J Gastroenterology. 2014;49(1):109–13. ID - ref90 ER - TY - STD TI - Liu B, Beral V, Balkwill A, Green J, Sweetland S, Reeves G; Million Women Study Collaborators. Gallbladder disease and use of transdermal versus oral hormone replacement therapy in postmenopausal women: prospective cohort study. BMJ. 2008;337:a386. ID - ref91 ER - TY - JOUR AU - Notelovitz, M. AU - Lenihan, J. P. AU - McDermott, M. AU - Kerber, I. J. AU - Nanavati, N. AU - Arce, J. PY - 2000 DA - 2000// TI - Initial 17beta-estradiol dose for treating vasomotor symptoms JO - Obstet Gynecol VL - 95 UR - https://doi.org/10.1016/S0029-7844(99)00643-2 DO - 10.1016/S0029-7844(99)00643-2 ID - Notelovitz2000 ER - TY - JOUR PY - 2005 DA - 2005// TI - Management of Menopause-Related Symptoms JO - Ann Intern Med VL - 142 UR - https://doi.org/10.7326/0003-4819-142-12_Part_1-200506210-00117 DO - 10.7326/0003-4819-142-12_Part_1-200506210-00117 ID - ref93 ER - TY - JOUR AU - Simon, J. A. PY - 2014 DA - 2014// TI - What if the Women’s Health Initiative had used transdermal estradiol and oral progesterone instead? JO - Menopause VL - 21 UR - https://doi.org/10.1097/GME.0000000000000169 DO - 10.1097/GME.0000000000000169 ID - Simon2014 ER - TY - JOUR AU - Stanczyk, F. Z. AU - Bhavnani, B. R. PY - 2014 DA - 2014// TI - Use of medroxyprogesterone acetate for hormone therapy in postmenopausal women: is it safe? JO - J Steroid Biochem Mol Biol VL - 142 UR - https://doi.org/10.1016/j.jsbmb.2013.11.011 DO - 10.1016/j.jsbmb.2013.11.011 ID - Stanczyk2014 ER - TY - JOUR AU - Grady, D. AU - Ettinger, B. AU - Tosteson, A. AU - Pressman, A. AU - Macer, J. PY - 2003 DA - 2003// TI - Discontinuing postmenopausal hormone therapy: predictors of difficulty stopping JO - Obstet Gynecol VL - 102 UR - https://doi.org/10.1016/j.obstetgynecol.2003.09.025 DO - 10.1016/j.obstetgynecol.2003.09.025 ID - Grady2003 ER -